GSKCONS

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding 'Voting Results and Scrutinizer s Report of Postal Ballot'.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding 'Intimation of newspaper publications with respect to the advertisement of notices of Tribunal convened Meetings of the Equity Shareholders and Unsecured Creditors of GlaxoSmithKline Consumer Healthcare Limited'.Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that pursuant to an order dated April 12, 2019 under Section 230(1) of the Companies Act, 2013 (��Act��) in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Chandigar

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding 'Strategic Review of Horlicks and Other Consumer Nutrition Products This is to notify that the Company notes the announcement by GlaxoSmithKline plc (GSK) of its intent to carry out a strategic review of GSK��s Horlicks and its other consumer nutrition products which will include an assessment of its 72.45% shareholding in the Company. The above may please be taken as our intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.'.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange thatat the Annual General Meeting of GlaxoSmithKline Consumer Healthcare Limited held on August 9, 2017 at 9.30 a.m. at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha 147 201 (Punjab), the Chairman ordered voting through Ballot Paper on all the resolutions mentioned in the Notice of the Annual General Meeting. The details of the voting results of the voting through Ballot Paper at the Annual General Meeting and the remote electronic voting on all the resolutions contained in the Notice shall b

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange vide letter dated June 15, 2016 regarding "Resumption of operations".

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Disclosure under Regulation 30(5) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that in accordance with the Company's Policy on Insider Trading, the date of commencement of closing of "Trading Window" shall be from July 03, 2014 and shall end 24 hours after public announcement of the Quarterly Financial Result for the first quarter (FY 2014 - 2015).

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that pursuant to the provisions of Section 108 of the Companies Act, 2013 and Rule 20(3)(vii) of the Companies (Management & Administration) Rules, 2014, the Company has fixed June 27, 2014 as the cut-off date to record the entitlement of the shareholders to cast their vote electronically at the Annual General Meeting (AGM) by electronic means under the Companies Act, 2013 and rules made there under. Consequently, the same cut-off date of June 27, 2014 would record entitlement of the shareholders, who do not cast their vote

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange that GSK Plc and Novartis AG have entered into an agreement to create Consumer Healthcare Joint Venture to hold GSK s Consumer Healthcare business and Novartis OTC Consumer Healthcare business. This Consumer Healthcare Joint Venture will exclude GlaxoSmithKline Consumer Healthcare Limited India, where GSK plc will continue to hold directly its interests in the listed entity.

Life Insurance Corporation of India has informed the Exchange vide letter dated February 18, 2013 that "As per the guideline on Institutional Transactions in shares issued by Govt. of India on February 20, 1990, we hereby inform that Life Insurance Corporation of India has sold 16,71,579 equity shares (of face value of Rs.10/- each) of GlaxoSmithkline Consumer Healthcare Ltd. @ Rs.3900/- per share".

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Abstract for appointment and remuneration of Mr. Ramakrishnan Subramanian, Wholetime Director.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of presentation which was made on November 29, 2011 by Managing Director to financial analysts.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "On 6th January, 2011 several newspapers carried Articles and interviews around launches of Sensodyne(R) Sensitive Toothpaste by GSK in India. We would like to clarify that the launch has been done by GSK Asia Private Ltd, our Associate Company in India and not by GlaxoSmithKline Consumer Healthcare Ltd. as reported in some newspapers".

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that "We had informed that due to unrest in the state of Andhra Pradesh and bandh called in the state by political parties, the management of GlaxoSmithKline Consumer Healthcare Limited temporarily suspended operations at one of its factories located at Industrial Estate Dowlaiswaram, Andhra Pradesh -533124. This is to inform you that the operations at the said factory have now resumed."

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "Due to unrest in the State of Andhra Pradesh and bandh called in the state by political parties, the management of Glaxosmithkline Consumer Healthcare Limited has decided to suspend operations temporarily at one of its factory located at Industrial Estate Dowlaiswaram, Andhra Pradesh - 533124 with effect from morning of today, December 11, 2009 in the interest of safety and security of its employees and to protect the assets of the factory".

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Abstract of the terms and conditions of the appointment and remuneration of Mr. Ramakrishnan Subramanian as a Wholetime Director has been circulated to all members of the Company on August 12, 2009, as per the requirements of Section 302 of Companies, Act, 1956. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gSK_abstract_20082009.zip target=NEW> For

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of an Abstract of the terms and conditions of the appointment and remuneration of Mr. Ramakrishnan Subramanian, Wholetime Director and variation in the term of remuneration of Mr. Praveen K Gupta, Wholetime Director. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Glaxo_Abs_14022008.zip target=NEW> For more details click here.</a>